In patients with EC showing high levels of ER and PR, favorable survival can be predicted; in contrast, when the gene of human epidermal growth factor receptor 2 (HER2) levels rise, the worst survival is observed due to the development of aggressive tumor characteristics [42, 43]. This evidence concerns the gene ERBB2 and neoplasm.